Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FE.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FE.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDBENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDBENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.81ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.572ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.572ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.397ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.397ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.3 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used